Major Semiconductor Stocks Tumble as AI Chip Rally Momentum Fades
Semiconductor stocks plummeted as Broadcom's AI revenue guidance signaled the industry's explosive growth may finally be hitting realistic limits.
Semiconductor stocks plummeted as Broadcom's AI revenue guidance signaled the industry's explosive growth may finally be hitting realistic limits.

Eli Lilly's stock hit an all-time high of $1,238 in June 2026, fueled by blockbuster earnings and a dominant GLP-1 drug portfolio capturing 65% of revenue.
Samsung's record $58 billion quarterly profit couldn't prevent a stock collapse, exposing the danger of valuation run-ups that price in perfection.

SpaceX's record $75 billion IPO dominated June headlines, but dividend and income ETFs delivered steady returns while space-themed funds soared on the speculation.

Samsung's earnings miss on July 7 triggered a 9% plunge in the Korean chip giant and broad semiconductor weakness, signaling investor concerns about AI demand and technology valuations.

RxSight's Q2 results reveal product sales weakness and steep profitability challenges ahead, prompting analyst downgrades and guidance cuts.

Global markets tumble as investors lose faith in the sustainability of massive AI capital spending.
This cascade of weakness in chip stocks rippled through the broader market, sending the S&P 500 down 1.5 percent and the Nasdaq Composite sliding 2.2...

Nextage's stock dropped 8% despite strong earnings and raised guidance, as profit-taking overwhelmed positive fundamentals.

SpaceX's Nasdaq inclusion and Fed rate hike signals collide to trigger $2 trillion in market losses and create conflicting pressures for traders this week.